Staph Infections More Common in Hospitalized Diabetics
Study finds they also have longer hospital stays, incur higher costs and have higher risk of death
THURSDAY, March 23 (HealthDay News) -- Hospitalized diabetics are twice as likely to develop Staphylococcus aureus infections as other patients, according to research presented this week at the International Conference on Emerging Infectious Diseases in Atlanta.
Shailendra Banerjee, Ph.D., of the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues performed a retrospective analysis using the data from 8 million inpatient stays from 994 hospitals in 37 states from the 2003 edition of the Agency for Healthcare Research and Quality's Nationwide Inpatient Sample database.
The researchers found that 2.3 percent of diabetic patients had S. aureus infection compared to 0.4 percent of all patients. They also found that diabetic patients with S. aureus infection had an average hospital stay of more than twice the length (11.5 versus 5.4 days), about twice the total hospital charges ($45,836 versus $24,061) and 2.5-times greater risk of in-hospital death (7.2 percent versus 2.76 percent) compared to those with diabetes but no S. aureus infection.
"S. aureus infections among diabetic patients represent a considerable burden to U.S. hospitals and patients," the authors conclude. "Preventing S. aureus infection among diabetic patients could reduce both patient mortality and health care costs."